ClinicalTrials.Veeva

Menu

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

U

University of Chinese Academy Sciences

Status and phase

Enrolling
Phase 2

Conditions

Nasopharyngeal Cancer
Neoplasm Metastasis

Treatments

Radiation: radical radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03129412
NPC-Oligo-M

Details and patient eligibility

About

Oligo-metastases NPC patients received radiation for primary tumors and treatments for metastatic lesions.

Full description

The patients enrolled will received 4-6 cycles chemotherapy at first.Then, radical radiotherapy for nasopharyngeal tumors and local treatments for oligometastatic lesions will assigned to those patients. The efficacy and side-effect will be evaluated and analyzed.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Histologically conformed initial non-keratinizing squamous carcinoma in nasopharynx.
  2. Clinical stages,T1-4N0-3M1,IVc(AJCC 2010).
  3. The metastatic lesions ≤5 and metastatic organs ≤2
  4. Karnofsky scores >70
  5. Normal hemodynamic indices before the recruitment (including white blood cell count>4.0×109/L, neutrophil count>1.5×109/L, platelet count >100×109/L, hemoglobin≥90g/l, normal liver/kidney function).
  6. Informed consent signed.

Exclusion criteria

  1. Histologically conformed initial keratinizing carcinoma or others.
  2. The metastatic lesions >5 or metastatic organs >2.
  3. Any severe complications contraindicated chemotherapy or radiotherapy.
  4. History of malignant tumors.
  5. Pregnant or nursing women.
  6. History of radiotherapy or chemotherpy in head and neck regions.
  7. Patients refused the informed consent.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

64 participants in 1 patient group

Arm 1
Experimental group
Description:
4-6 cycles chemotherapy and radical radiotherapy for primary tumors were given. Appropriate treatments for olio-metastatic lesions will assigned to those who got PR,SD after chemotherapy.
Treatment:
Radiation: radical radiotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Shuang Huang, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems